MedPath
HSA Approval

PULMOXYL - 500 CAPSULE 500 mg (Maroon/yellow)

SIN11190P

PULMOXYL - 500 CAPSULE 500 mg (Maroon/yellow)

PULMOXYL - 500 CAPSULE 500 mg (Maroon/yellow)

September 24, 1999

NAINA MOHAMED & SONS PRIVATE LIMITED

NAINA MOHAMED & SONS PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNAINA MOHAMED & SONS PRIVATE LIMITED
Licence HolderNAINA MOHAMED & SONS PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

**DOSAGE:** Adults: 250mg every 8 hours. Children: 20 mg/kg/day in divided doses every 8 hours. In severe infections the above dose may be doubled. Gonorrhoea: Adults: 3 grams as single oral dose. Except for gonorrhoea, treatment should be continued for a minimum of 48 to 72 hours after the patient becomes asymptomatic.

ORAL

Medical Information

**INDICATIONS:** Treatment of infections due to susceptible strains of the following: Gram-negative organisms: H Influenzae, E.coli, P mirabilis, N. Gonorrhoeae. Gram-positive organisms: Streptococci, D. pneumoniae and non-penicillina seproducing staphylococci.

**CONTRAINDICATIONS:** History _of_ allergic reactions to pencillins.

J01CA04

amoxicillin

Manufacturer Information

NAINA MOHAMED & SONS PRIVATE LIMITED

MICRO LABS LTD

Active Ingredients

AMOXICILLIN TRIHYDRATE 575 mg EQV AMOXICILLIN

500.00 mg

Amoxicillin

Documents

Package Inserts

Pulmoxyl-500 Capsule PI.pdf

Approved: September 29, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PULMOXYL - 500 CAPSULE 500 mg (Maroon/yellow) - HSA Approval | MedPath